Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02625441
Brief Title: Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer (BOLD-1)

First Submitted : December 5, 2015
First Submitted that Met QC Criteria : December 8, 2015
First Posted : December 9, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 25, 2018
Last Update Posted : August 28, 2018